Displaying 1 - 50 of 97 results
Released Company Title Industry Topic
19 Dec 2024
17:58 CET
ONWARD MEDICAL ONWARD® Medical reçoit la classification De Novo de la FDA et l'autorisation de mise sur le marché américain pour le premier système non invasif au monde de stimulation de la moelle épinière destiné aux personnes atteintes de lésion chroniqu... 20101025 Health Services -
19 Dec 2024
17:58 CET
ONWARD MEDICAL ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury 20101025 Health Services -
12 Dec 2024
07:30 CET
ONWARD MEDICAL ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability 20101025 Health Services -
26 Nov 2024
07:30 CET
ONWARD MEDICAL ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights 20101025 Health Services -
19 Nov 2024
07:30 CET
ONWARD MEDICAL ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke 20101025 Health Services -
12 Nov 2024
07:30 CET
ONWARD MEDICAL ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights 20101025 Health Services -
31 Oct 2024
06:30 CET
ONWARD MEDICAL ONWARD ARC-EX® System Named One of TIME's Best Inventions of 2024 20101025 Health Services -
28 Oct 2024
17:45 CET
ONWARD MEDICAL ONWARD® Medical Publishes Closing of Bookbuild Offering 20101025 Health Services -
24 Oct 2024
17:45 CEST
ONWARD MEDICAL ONWARD® Medical Publishes Prospectus for Listing of New Shares 20101025 Health Services -
24 Oct 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical lève avec succès 50 millions d’euros dans le cadre d’une levée de fonds majorée avec le soutien d’Ottobock SE & Co. KGaA 20101025 Health Services -
24 Oct 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA 20101025 Health Services -
22 Oct 2024
20:21 CEST
ONWARD MEDICAL ONWARD® Medical lance une augmentation de capital d’un montant d’environ 40 millions d’euros dont 22,5 millions d’engagement ferme de la part d’Ottobock SE & Co. KGaA 20101025 Health Services -
22 Oct 2024
17:45 CEST
ONWARD MEDICAL ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA 20101025 Health Services -
21 Oct 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical Announces Changes to Board of Directors, Including Addition of Medtech Leader Rob ten Hoedt as Incoming Chairman 20101025 Health Services -
15 Oct 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d’interface cerveau machine (BCI) WIMAGINE® de Clinatec 20101025 Health Services -
15 Oct 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology 20101025 Health Services -
20 Sep 2024
19:45 CEST
ONWARD MEDICAL ONWARD® Medical Annonce la Cotation de ses Titres sur le Marché Euronext Paris 20101025 Health Services -
19 Sep 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine (BCI) pour restaurer le mouvement après une lésion de la moelle épinière 20101025 Health Services -
19 Sep 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury 20101025 Health Services -
10 Sep 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update 20101025 Health Services -
03 Sep 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System 20101025 Health Services -
27 Aug 2024
18:53 CEST
ONWARD MEDICAL ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update 20101025 Health Services -
05 Aug 2024
23:47 CEST
ONWARD MEDICAL ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights 20101025 Health Services -
17 Jul 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical Publishes Annual Sustainability Summary 20101025 Health Services -
09 Jul 2024
19:18 CEST
ONWARD MEDICAL ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy 20101025 Health Services -
28 Jun 2024
23:53 CEST
ONWARD MEDICAL ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC 20101025 Health Services -
26 Jun 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical Announces Participation in Stifel European Healthcare Summit 20101025 Health Services -
18 Jun 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference 20101025 Health Services -
13 Jun 2024
23:36 CEST
ONWARD MEDICAL ONWARD® Medical Announces Results of Annual General Meeting of Shareholders 20101025 Health Services -
24 May 2024
03:19 CEST
ONWARD MEDICAL ONWARD® Medical berichtet über das 1. Quartal 2024 und die bisherigen Höhepunkte des Jahres 20101025 Health Services -
24 May 2024
03:19 CEST
ONWARD MEDICAL ONWARD® Medical fait le point sur le premier trimestre 2024 et sur les faits marquants de l’année écoulée 20101025 Health Services -
23 May 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights 20101025 Health Services -
22 May 2024
19:13 CEST
ONWARD MEDICAL ONWARD® Medical organise une téléconférence pour partager les détails relatifs à son étude clinique Up-LIFT et à sa publication dans la revue Nature Medicine 20101025 Health Services -
22 May 2024
19:13 CEST
ONWARD MEDICAL ONWARD® Medical veranstaltet Webcast zu Einzelheiten der Up-LIFT-Studie und der aktuellen Veröffentlichung in Nature Medicine 20101025 Health Services -
21 May 2024
23:53 CEST
ONWARD MEDICAL Nature Medicine se réjouit de partager l’amélioration significative de la fonction de la main et du bras après une lésion de la moelle épinière grâce à la thérapie ONWARD® ARC-EX® Therapy 20101025 Health Services -
21 May 2024
23:53 CEST
ONWARD MEDICAL Nature Medicine hebt signifikante Verbesserung der Hand- und Armfunktion nach einer Rückenmarksverletzung durch die ONWARD® ARC-EX® Therapie hervor 20101025 Health Services -
21 May 2024
18:25 CEST
ONWARD MEDICAL ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication 20101025 Health Services -
20 May 2024
17:35 CEST
ONWARD MEDICAL Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy 20101025 Health Services -
16 May 2024
00:43 CEST
ONWARD MEDICAL ONWARD® Medical plant Webcast zur Vorstellung des Geschäftsverlaufs im 1. Quartal 2024 20101025 Health Services -
16 May 2024
00:43 CEST
ONWARD MEDICAL ONWARD® Medical organise un webinaire pour présenter l’état des lieux de ses activités du premier trimestre 2024 20101025 Health Services -
15 May 2024
00:21 CEST
ONWARD MEDICAL ONWARD® Medical Schedules Webcast to Provide Q1 2024 Business Update 20101025 Health Services -
03 May 2024
03:31 CEST
ONWARD MEDICAL Avis de convocation à l’assemblée générale 2024 des actionnaires ONWARD® et propositions de résolutions 20101025 Health Services -
02 May 2024
07:00 CEST
ONWARD MEDICAL ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions 20101025 Health Services -
26 Apr 2024
15:17 CEST
ONWARD MEDICAL ONWARD® Medical annonce ses résultats financiers et opérationnels pour l’exercice 2023 et partage les faits qui ont marqué l’exercice 2024 à ce jour 20101025 Health Services -
25 Apr 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date 20101025 Health Services -
11 Apr 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update Webcast 20101025 Health Services -
09 Apr 2024
07:00 CEST
ONWARD MEDICAL Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00 20101025 Health Services -
02 Apr 2024
07:30 CEST
ONWARD MEDICAL ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System 20101025 Health Services -
25 Mar 2024
17:40 CET
ONWARD MEDICAL ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public Offering in France 20101025 Health Services -
21 Mar 2024
18:26 CET
ONWARD MEDICAL ONWARD® Medical Publishes Prospectus for Listing of New Shares 20101025 Health Services -